On-Demand Data Management Webinars

  1. Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design 1/28/2026

    Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

  2. Unified Data + Trustworthy AI Drives Strategic Precision 1/25/2026

    Data quality and governance underpin portfolio, clinical trial, and commercial decisions. Combined with trustworthy, explainable AI, they enable complete insights for optimization, feasibility, forecasting, and planning.

  3. AI And Multi-Omics For Translational Research 1/20/2026

    Explore the innovations driving drug discovery breakthroughs and shaping future-ready strategies.

  4. Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints 1/15/2026

    Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.

  5. How Biotech Gets Built With Professor Justin Stebbing 1/14/2026

    Navigate the complexities of biotech innovation by exploring how AI, the GLP-1 revolution, and shifting global trial trends are redefining the path to safer, more effective patient treatments.

  6. The Connected Patient In Clinical Trials 12/23/2025

    Discover how digital innovation and patient-centric technologies are reshaping clinical trials by improving access, efficiency, and data-driven insights.

  7. Key Trends Driving Digital Transformation In Clinical Research 12/10/2025

    AI, sensors, and evolving regulations are redefining digital health—driving data insights, sensor-based endpoints, and regulatory pathways that shape the future of clinical research.

     

  8. New ICH GCP Changes Center The Patient 12/8/2025

    Explore key changes to the guidelines and how they're transforming clinical trials with a focus on patient centricity, digital innovation, and risk-based quality management.

  9. De-Risking Strategies For Schizophrenia Programs 11/18/2025

    Dr. Jeffrey Lieberman, Dr. Alan Kott, and Dr. Chris Murphy dissect why Phase 3 failures are increasing, how data quality issues cluster at specific sites, and why inadequate dose-response mapping continues to derail programs.

  10. EU GMP Annex 11: Compliance Strategy And Digital Solutions 11/18/2025

    Explore how EU GMP Annex 11 revisions could reshape global pharmaceutical compliance, as well as strategies for navigating implementation challenges and building future-ready validation programs.